Hotchkis & Wiley Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.16M | Buy |
29,760
+20
| +0.1% | +$2.12K | 0.01% | 447 |
|
|
2025
Q1 | $3.69M | Sell |
29,740
-11,775
| -28% | -$1.46M | 0.01% | 404 |
|
|
2024
Q4 | $5.11M | Sell |
41,515
-5
| -0% | -$616 | 0.02% | 390 |
|
|
2024
Q3 | $4.63M | Buy |
41,520
+75
| +0.2% | +$8.36K | 0.02% | 399 |
|
|
2024
Q2 | $4.42M | Buy |
41,445
+10
| +0% | +$1.07K | 0.02% | 396 |
|
|
2024
Q1 | $4.99M | Buy |
41,435
+21,600
| +109% | +$2.6M | 0.02% | 393 |
|
|
2023
Q4 | $2.44M | Buy |
19,835
+3,800
| +24% | +$467K | 0.01% | 460 |
|
|
2023
Q3 | $2.08M | Sell |
16,035
-50
| -0.3% | -$6.47K | 0.01% | 461 |
|
|
2023
Q2 | $1.99M | Buy |
16,085
+20
| +0.1% | +$2.48K | 0.01% | 469 |
|
|
2023
Q1 | $2.35M | Hold |
16,065
| – | – | 0.01% | 432 |
|
|
2022
Q4 | $2.56M | Buy |
16,065
+65
| +0.4% | +$10.4K | 0.01% | 426 |
|
|
2022
Q3 | $2.13M | Hold |
16,000
| – | – | 0.01% | 444 |
|
|
2022
Q2 | $2.5M | Sell |
16,000
-18,700
| -54% | -$2.92M | 0.01% | 428 |
|
|
2022
Q1 | $5.4M | Buy |
34,700
+300
| +0.9% | +$46.7K | 0.02% | 332 |
|
|
2021
Q4 | $4.38M | Sell |
34,400
-500
| -1% | -$63.7K | 0.01% | 370 |
|
|
2021
Q3 | $4.54M | Buy |
+34,900
| New | +$4.54M | 0.01% | 345 |
|